Post by
13PunterDog on Jan 15, 2016 2:37pm
Market Slaughter
...and we're up!! After approval we will be a way over priced stock. Just law of averages due to being undervalued for years.JMHO
GLTALongs
13PD
Comment by
Hatchchat on Jan 15, 2016 5:16pm
What exactly do you mean by over priced? What do you consider as a fair price?
Comment by
noinstinct89 on Jan 15, 2016 6:28pm
13PD, I wonder why TST never mentioned Oncoc. yet, I mean, they could list it as part of their pipe. But they don't. Why? It showed an activity in animals but the efficacy in human remains to be seen.
Comment by
13PunterDog on Jan 15, 2016 11:42pm
I guess they are concentrating on just Bladder Cancer for now. They finished Phase I MCC ( what they called MCNA before ) for Prostate Cancer too, I believe. It has been forgotten that MCC / MCNA are for other things as well , but management has put all on the back burner as I recall them saying a few years ago. Cheers 13PD
Comment by
Tson99 on Jan 16, 2016 11:37am
Actually I think it has been given to humans. I remember reading somewhere that they gave it 12 people that I think were part of one of the studies. Can't remember off the top of my head. Beech would probably know, or one of the other long timers.
Comment by
Frogger2 on Jan 16, 2016 4:45pm
I actually asked Olds this question quite a while ago. TST owns all rights to human and has full control of what Grarme does with animal.
Comment by
13PunterDog on Jan 16, 2016 5:03pm
I knew I read that in someones post a while back. Thanks for posting. Does anyone live in the Montreal area who can drive by and spy on the production facility?Is it busy? Parking lot full and active?etc. Should be about the time FDA starts to show up to give final review of the facility. Probably would be the best way to get a clue of whats going on. GLTALongs 13PD